These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2688680)

  • 21. Thrombosis and the development of atherosclerosis: Rokitansky revisited.
    Schwartz CJ; Valente AJ; Kelley JL; Sprague EA; Edwards EH
    Semin Thromb Hemost; 1988 Apr; 14(2):189-95. PubMed ID: 3061004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrin and its derivatives in the normal and diseased vessel wall.
    Bini A; Kudryk BJ
    Ann N Y Acad Sci; 1992 Dec; 667():112-26. PubMed ID: 1309030
    [No Abstract]   [Full Text] [Related]  

  • 23. The structure of soluble fibrin complexes and fibrin degradation products after Echis carinatus bite.
    Edgar W; Warrell MJ; Warrell DA; Prentice CR
    Br J Haematol; 1980 Mar; 44(3):471-81. PubMed ID: 7378311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atherogenesis during low level hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque.
    Masuda J; Ross R
    Arteriosclerosis; 1990; 10(2):178-87. PubMed ID: 2317156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A diazophenylthio-ether-IgG probe for analysing fibrin- and fibrinogen-related antigens.
    Kruskal JB; Maeder DL; Purves LR; Franks JJ; Kirsch RE
    S Afr Med J; 1987 Feb; 71(4):211-7. PubMed ID: 3824087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipids and plasma fibrinogen: early and late composition of the atherosclerotic plaque.
    Smith EB
    Cardiologia; 1994 Dec; 39(12 Suppl 1):169-72. PubMed ID: 7634262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinogen and smooth muscle cell detection in atherosclerotic plaques from stable and unstable angina -- an immunohistochemical study.
    Loukas M; Dabrowski M; Wagner T; Walczak E; Witkowski A; Ruzyłło W
    Med Sci Monit; 2002 Apr; 8(4):BR144-8. PubMed ID: 11951060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture.
    Ishida T; Tanaka K
    Atherosclerosis; 1982 Aug; 44(2):161-74. PubMed ID: 7138618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative immunochemical determination of degradation products of fibrinogen and-or fibrin with high voltage electrophoresis.
    Niléhn JE
    Scand J Haematol Suppl; 1971; 13():215-7. PubMed ID: 5290683
    [No Abstract]   [Full Text] [Related]  

  • 30. Presence of growth-stimulating fibrin degradation products containing fragment E in human atherosclerotic plaques.
    Stirk CM; Kochhar A; Smith EB; Thompson WD
    Atherosclerosis; 1993 Nov; 103(2):159-69. PubMed ID: 7507326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
    Dyr JE; Cajthamlová H; Suttnar J
    Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrin and fibrinogen-related antigens in systemic sclerosis (scleroderma).
    Falanga V; Kruskal JB; Franks JJ
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):771-5. PubMed ID: 1802898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation of soluble fibrinogen-fibrin complex in liquid human plasma; reflexion of coagulation process in storage.
    Abe T; Kazama M; Tahara C; Miura Y; Yasuda J
    Jpn J Med Sci Biol; 1977 Apr; 30(2):91-9. PubMed ID: 916354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies to different neo-epitopes on fibrinogen and fibrin degradation products.
    Amiral J; Grosley M; Mimilla F; Plassart V; Chambrette B
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):447-52. PubMed ID: 1723302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinogen-fibrin: preparation and use of monoclonal antibodies as diagnostics.
    Kudryk BJ; Bini A; Rosebrough SF; Schaible TF
    Biotechnology; 1991; 19():281-313. PubMed ID: 1723912
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction.
    Francis CW; Connaghan DG; Scott WL; Marder VJ
    Circulation; 1987 Jun; 75(6):1170-7. PubMed ID: 3568326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinogen, fibrin turnover, endothelial products and vascular surgery.
    Woodburn KR; Lowe GD
    Br J Surg; 1997 Aug; 84(8):1059-64. PubMed ID: 9278641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infiltration and thrombosis in atherogenesis. A study using immunofluorescent techniques.
    Woolf N; Carstairs KC
    Am J Pathol; 1967 Sep; 51(3):373-86. PubMed ID: 5341398
    [No Abstract]   [Full Text] [Related]  

  • 39. Fibrinogen and fibrinolysis in blood and in the arterial wall: its role in advanced atherosclerotic disease.
    Martin-Paredero V; Vadillo J; Diaz J; Espinosa A; Berga C; Segura J; Sanchez J; Barbod A; Villaverde C; Richard CM
    Cardiovasc Surg; 1998 Oct; 6(5):457-62. PubMed ID: 9794264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoelectrophoretic and immunohistochemical characterizations of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas.
    Valenzuela R; Shainoff JR; DiBello PM; Urbanic DA; Anderson JM; Matsueda GR; Kudryk BJ
    Am J Pathol; 1992 Oct; 141(4):861-80. PubMed ID: 1415480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.